Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New predictors for immunotherapy responses sharpen our view of the tumour microenvironment.

Literature DB >> 31965091

New predictors for immunotherapy responses sharpen our view of the tumour microenvironment.

Tullia C Bruno.

Abstract

Entities: Chemical

Keywords: Cancer; Immunology; Medical research

Mesh：

Substances：
Immunologic Factors

Year: 2020 PMID： 31965091 PMCID： PMC7523515 DOI： 10.1038/d41586-019-03943-0

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 69.504

× No keyword cloud information.

13 in total

1. Antigen-Presenting Intratumoral B Cells Affect CD4⁺ TIL Phenotypes in Non-Small Cell Lung Cancer Patients.

Authors: Tullia C Bruno; Peggy J Ebner; Brandon L Moore; Olivia G Squalls; Katherine A Waugh; Evgeniy B Eruslanov; Sunil Singhal; John D Mitchell; Wilbur A Franklin; Daniel T Merrick; Martin D McCarter; Brent E Palmer; Jeffrey A Kern; Jill E Slansky
Journal: Cancer Immunol Res Date: 2017-08-28 Impact factor: 11.151

2. Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens.

Authors: Jeff DeFalco; Michael Harbell; Amy Manning-Bog; Gilson Baia; Alexander Scholz; Beatriz Millare; May Sumi; Danhui Zhang; Felix Chu; Christine Dowd; Patricia Zuno-Mitchell; Dongkyoon Kim; Yvonne Leung; Shuwei Jiang; Xiaobin Tang; Kevin S Williamson; Xiaomu Chen; Sean M Carroll; Gregg Espiritu Santo; Nicole Haaser; Ngan Nguyen; Eldar Giladi; David Minor; Yann Chong Tan; Jeremy B Sokolove; Lawrence Steinman; Tito A Serafini; Guy Cavet; Norman M Greenberg; Jacob Glanville; Wayne Volkmuth; Daniel E Emerling; William H Robinson
Journal: Clin Immunol Date: 2017-10-12 Impact factor: 3.969

3. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.

Authors: Aharon Kessel; Tharwat Haj; Regina Peri; Ayelet Snir; Doron Melamed; Edmond Sabo; Elias Toubi
Journal: Autoimmun Rev Date: 2011-12-02 Impact factor: 9.754

4. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.

Authors: Claire Germain; Sacha Gnjatic; Fella Tamzalit; Samantha Knockaert; Romain Remark; Jérémy Goc; Alice Lepelley; Etienne Becht; Sandrine Katsahian; Geoffray Bizouard; Pierre Validire; Diane Damotte; Marco Alifano; Pierre Magdeleinat; Isabelle Cremer; Jean-Luc Teillaud; Wolf-Herman Fridman; Catherine Sautès-Fridman; Marie-Caroline Dieu-Nosjean
Journal: Am J Respir Crit Care Med Date: 2014-04-01 Impact factor: 21.405

5. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.

Authors: Julie R Brahmer; Charles G Drake; Ira Wollner; John D Powderly; Joel Picus; William H Sharfman; Elizabeth Stankevich; Alice Pons; Theresa M Salay; Tracee L McMiller; Marta M Gilson; Changyu Wang; Mark Selby; Janis M Taube; Robert Anders; Lieping Chen; Alan J Korman; Drew M Pardoll; Israel Lowy; Suzanne L Topalian
Journal: J Clin Oncol Date: 2010-06-01 Impact factor: 44.544

6. B cells are associated with survival and immunotherapy response in sarcoma.

Authors: Florent Petitprez; Aurélien de Reyniès; Emily Z Keung; Tom Wei-Wu Chen; Cheng-Ming Sun; Julien Calderaro; Yung-Ming Jeng; Li-Ping Hsiao; Laetitia Lacroix; Antoine Bougoüin; Marco Moreira; Guillaume Lacroix; Ivo Natario; Julien Adam; Carlo Lucchesi; Yec Han Laizet; Maud Toulmonde; Melissa A Burgess; Vanessa Bolejack; Denise Reinke; Khalid M Wani; Wei-Lien Wang; Alexander J Lazar; Christina L Roland; Jennifer A Wargo; Antoine Italiano; Catherine Sautès-Fridman; Hussein A Tawbi; Wolf H Fridman
Journal: Nature Date: 2020-01-15 Impact factor: 49.962

7. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.

Authors: Rita Cabrita; Martin Lauss; Adriana Sanna; Marco Donia; Mathilde Skaarup Larsen; Shamik Mitra; Iva Johansson; Bengt Phung; Katja Harbst; Johan Vallon-Christersson; Alison van Schoiack; Kristina Lövgren; Sarah Warren; Karin Jirström; Håkan Olsson; Kristian Pietras; Christian Ingvar; Karolin Isaksson; Dirk Schadendorf; Henrik Schmidt; Lars Bastholt; Ana Carneiro; Jennifer A Wargo; Inge Marie Svane; Göran Jönsson
Journal: Nature Date: 2020-01-15 Impact factor: 49.962

8. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.

Authors: Shabnam Shalapour; Joan Font-Burgada; Giuseppe Di Caro; Zhenyu Zhong; Elsa Sanchez-Lopez; Debanjan Dhar; Gerald Willimsky; Massimo Ammirante; Amy Strasner; Donna E Hansel; Christina Jamieson; Christopher J Kane; Tobias Klatte; Peter Birner; Lukas Kenner; Michael Karin
Journal: Nature Date: 2015-04-29 Impact factor: 49.962

9. Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.

Authors: Alexander Shimabukuro-Vornhagen; Hans A Schlößer; Luise Gryschok; Joke Malcher; Kerstin Wennhold; Maria Garcia-Marquez; Till Herbold; Laura S Neuhaus; Hans J Becker; Anne Fiedler; Pascal Scherwitz; Thomas Koslowsky; Roland Hake; Dirk L Stippel; Arnulf H Hölscher; Sebastian Eidt; Michael Hallek; Sebastian Theurich; Michael S von Bergwelt-Baildon
Journal: Oncotarget Date: 2014-07-15

10. B cells and tertiary lymphoid structures promote immunotherapy response.

Authors: Beth A Helmink; Sangeetha M Reddy; Jianjun Gao; Shaojun Zhang; Rafet Basar; Rohit Thakur; Keren Yizhak; Moshe Sade-Feldman; Jorge Blando; Guangchun Han; Vancheswaran Gopalakrishnan; Yuanxin Xi; Hao Zhao; Rodabe N Amaria; Hussein A Tawbi; Alex P Cogdill; Wenbin Liu; Valerie S LeBleu; Fernanda G Kugeratski; Sapna Patel; Michael A Davies; Patrick Hwu; Jeffrey E Lee; Jeffrey E Gershenwald; Anthony Lucci; Reetakshi Arora; Scott Woodman; Emily Z Keung; Pierre-Olivier Gaudreau; Alexandre Reuben; Christine N Spencer; Elizabeth M Burton; Lauren E Haydu; Alexander J Lazar; Roberta Zapassodi; Courtney W Hudgens; Deborah A Ledesma; SuFey Ong; Michael Bailey; Sarah Warren; Disha Rao; Oscar Krijgsman; Elisa A Rozeman; Daniel Peeper; Christian U Blank; Ton N Schumacher; Lisa H Butterfield; Monika A Zelazowska; Kevin M McBride; Raghu Kalluri; James Allison; Florent Petitprez; Wolf Herman Fridman; Catherine Sautès-Fridman; Nir Hacohen; Katayoun Rezvani; Padmanee Sharma; Michael T Tetzlaff; Linghua Wang; Jennifer A Wargo
Journal: Nature Date: 2020-01-15 Impact factor: 69.504

30 in total

Review 1. Hepatocellular carcinoma.

Authors: Josep M Llovet; Robin Kate Kelley; Augusto Villanueva; Amit G Singal; Eli Pikarsky; Sasan Roayaie; Riccardo Lencioni; Kazuhiko Koike; Jessica Zucman-Rossi; Richard S Finn
Journal: Nat Rev Dis Primers Date: 2021-01-21 Impact factor: 52.329

2. Molecular Signature of Tumor-Associated High Endothelial Venules That Can Predict Breast Cancer Survival.

Authors: Junko Sawada; Nobuyoshi Hiraoka; Rongsu Qi; Lu Jiang; Ashley E Fournier-Goss; Masayuki Yoshida; Hiroto Kawashima; Masanobu Komatsu
Journal: Cancer Immunol Res Date: 2022-04-01 Impact factor: 12.020

Review 3. Immunotherapies for hepatocellular carcinoma.

Authors: Josep M Llovet; Florian Castet; Mathias Heikenwalder; Mala K Maini; Vincenzo Mazzaferro; David J Pinato; Eli Pikarsky; Andrew X Zhu; Richard S Finn
Journal: Nat Rev Clin Oncol Date: 2021-11-11 Impact factor: 65.011

4. Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression.

Authors: Lucile Vanhersecke; Maxime Brunet; Jean-Philippe Guégan; Christophe Rey; Antoine Bougouin; Sophie Cousin; Sylvestre Le Moulec; Benjamin Besse; Yohann Loriot; Mathieu Larroquette; Isabelle Soubeyran; Maud Toulmonde; Guilhem Roubaud; Simon Pernot; Mathilde Cabart; François Chomy; Corentin Lefevre; Kevin Bourcier; Michèle Kind; Ilenia Giglioli; Catherine Sautès-Fridman; Valérie Velasco; Félicie Courgeon; Ezoglin Oflazoglu; Ariel Savina; Aurélien Marabelle; Jean-Charles Soria; Carine Bellera; Casimir Sofeu; Alban Bessede; Wolf H Fridman; François Le Loarer; Antoine Italiano
Journal: Nat Cancer Date: 2021-08-12

5. IgA-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial Cancer.

Authors: Gunjan Mandal; Subir Biswas; Carmen M Anadon; Xiaoqing Yu; Chandler D Gatenbee; Sandhya Prabhakaran; Kyle K Payne; Ricardo A Chaurio; Alexandra Martin; Patrick Innamarato; Carlos Moran; John J Powers; Carly M Harro; Jessica A Mine; Kimberly B Sprenger; Kristen E Rigolizzo; Xuefeng Wang; Tyler J Curiel; Paulo C Rodriguez; Alexander R Anderson; Ozlen Saglam; Jose R Conejo-Garcia
Journal: Cancer Res Date: 2022-03-01 Impact factor: 13.312

6. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.

Authors: Wei Han; Biao Huang; Xiao-Yu Zhao; Guo-Liang Shen
Journal: Biosci Rep Date: 2020-11-27 Impact factor: 3.840

Review 7. Interferon-γ: teammate or opponent in the tumour microenvironment?

Authors: Angela M Gocher; Creg J Workman; Dario A A Vignali
Journal: Nat Rev Immunol Date: 2021-06-21 Impact factor: 53.106

8. Association between body mass index and survival outcomes for cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.

Authors: Yue An; Zhonghua Wu; Ningning Wang; Zhidong Yang; Yue Li; Boyang Xu; Mingjun Sun
Journal: J Transl Med Date: 2020-06-12 Impact factor: 5.531

Review 9. Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment.

Authors: Ellen N Scott; Angela M Gocher; Creg J Workman; Dario A A Vignali
Journal: Front Immunol Date: 2021-06-10 Impact factor: 7.561

10. Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication.

Authors: Fangfang Liu; Thomas Hardiman; Kailiang Wu; Jelmar Quist; Patrycja Gazinska; Tony Ng; Arnie Purushotham; Roberto Salgado; Xiaojing Guo; Sarah E Pinder; Anita Grigoriadis
Journal: NPJ Breast Cancer Date: 2021-07-05